Assura’s (AGR) “Buy” Rating Reaffirmed at Liberum Capital

Liberum Capital reissued their buy rating on shares of Assura (LON:AGR) in a research note published on Wednesday.

Separately, Peel Hunt reaffirmed a hold rating on shares of Assura in a research note on Thursday, November 22nd.

AGR traded down GBX 0.30 ($0.00) on Wednesday, hitting GBX 54.50 ($0.71). 5,024,381 shares of the company traded hands, compared to its average volume of 2,800,000. Assura has a 12-month low of GBX 55.95 ($0.73) and a 12-month high of GBX 67.30 ($0.88).

Assura (LON:AGR) last posted its quarterly earnings data on Thursday, November 22nd. The real estate investment trust reported GBX 1.30 ($0.02) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of GBX 1.40 ($0.02) by GBX (0.10) ($0.00).

The business also recently disclosed a dividend, which will be paid on Wednesday, January 16th. Shareholders of record on Thursday, December 13th will be paid a dividend of GBX 0.69 ($0.01) per share. The ex-dividend date is Thursday, December 13th. This is an increase from Assura’s previous dividend of $0.66. This represents a yield of 1.26%.

About Assura

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high-quality patient care in the community.

Further Reading: The mechanics of the bid-ask spread in trading

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit